Skip to content
Search

Latest Stories

Online pharmacy PillTime installs Titan PMR in its new state-of-art facility to boost prescription growth

Online pharmacy PillTime has taken a step to boost its prescription growth by implementing new Patient Medication Record (PMR) system Titan in its state-of-the-art premises.

PillTime moved to new, expanded 26,000sqft premises in Cribbs Causeway on the edge of Bristol earlier this year, where it has also installed state-of-the-art robotics in a bid to significantly enhance future productivity and capacity.


Teething problems over Easter weekend saw PillTime struggling to seamlessly integrate all the new systems and processes while physically moving premises which affected service delivery and customer support.

However, CEO Leighton Humphreys was supported by Tariq Muhammad, CEO of Invatech Health, who is a former community pharmacist and has worked with independent pharmacies around the UK as well as larger online businesses, to integrate Titan into their workflows.

Alongside integration work, Muhammad and his team supported PillTime with necessary design, governance and pharmacy expertise as the company struggled to meet its usual high standards for dispensing medicines to patients.

“We had ambitious plans for our move but things turned out to be more complicated than we had envisaged,” said Humphreys. “So we are extremely grateful to Tariq and his team of pharmacists for the support they provided.

“We thank our customers for sticking with us during this challenging period for our business and we’re looking ahead now. Titan will make a major difference to how we operate and grow, alongside the cutting-edge robotics and innovative pouching system which are unique at this scale.”

Founded in 2016, PillTime currently provides prescription medicines in daily dosage pouches to around 11,000 NHS patients across the UK.

Following the deployment of Titan, it forecasts 900 per cent growth in the next two to three years. It hopes to hit the 100,000 patient mark by the end of 2023 – a figure it says is still ‘only a drop in the ocean’.

Last year Invatech Health announced a further £950,000 loan from Innovate UK, under a programme to support game-changing innovations in the UK’s SME community.

Muhammad, said he was pleased to support PillTime.

“Having established our systems in the community pharmacy sector, we are now enjoying rolling out Titan Enterprise to innovative online pharmacy businesses,” he said, adding: “We’re helping them process prescriptions safely at a speed which is unheard of until now.

“Of course It’s great to be collaborating with another innovative Bristol-based business which is looking to help transform the way that people manage and access their medication.

“Now all systems are fully operational, we are excited to see how PillTime develops over the coming months and years.”

Humphreys said that PillTime’s offering of medication in easy-to-understand pouches provided a solution to several problems, from reducing the requirement for carers and nursing homes, while minimising hospital admissions through medication errors.

“There are far too many instances of medications being properly dispensed but incorrectly taken, leading to people not getting better as they should do,” he said.

“In some parts of the world the pouching system has become standard because it’s foolproof, as long as the patient is fully aware. We want that to happen here, too. Our mission is cost savings to the NHS and a better quality of convenience and level of healthcare. “

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less